In today's episode, Christian Esguerra tackles the decision by the Philippine Food and Drug Administration to suspend the administration of AstraZeneca's COVID-19 vaccine to people below 60 years old. Is there enough evidence linking this to a rare blood clotting episode? And how will this affect the vaccination program in the Philippines which has been criticized fore being slow? He also talks about the safety and efficacy of the anti-parisitic drug Ivermectin as the FDA grants one undisclosed hospital a compassionate use permit for the drug's use to treat COVID-19.

And how is the situation in local governments two weeks into the enhanced community quarantine? Is the lockdown aid allocated enough?